Royal Bank of Canada’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.19M | Buy |
625,035
+16,576
| +3% | +$53K | ﹤0.01% | 3022 |
|
|
2025
Q4 | $1.66M | Sell |
608,459
-946,354
| -61% | -$2.19M | ﹤0.01% | 3259 |
|
|
2025
Q3 | $3.38M | Sell |
1,554,813
-824,275
| -35% | -$1.95M | ﹤0.01% | 2982 |
|
|
2025
Q2 | $4.09M | Buy |
2,379,088
+1,856,201
| +355% | +$4.62M | ﹤0.01% | 2726 |
|
|
2025
Q1 | $1.74M | Buy |
522,887
+322,680
| +161% | +$1.66M | ﹤0.01% | 3046 |
|
|
2024
Q4 | $1.48M | Sell |
200,207
-8,957
| -4% | -$83K | ﹤0.01% | 3237 |
|
|
2024
Q3 | $1.96M | Buy |
209,164
+72,830
| +53% | +$690K | ﹤0.01% | 3013 |
|
|
2024
Q2 | $1.09M | Buy |
136,334
+37,189
| +38% | +$399K | ﹤0.01% | 3374 |
|
|
2024
Q1 | $1.47M | Buy |
99,145
+17,164
| +21% | +$200K | ﹤0.01% | 3157 |
|
|
2023
Q4 | $667K | Buy |
81,981
+39,961
| +95% | +$209K | ﹤0.01% | 4009 |
|
|
2023
Q3 | $191K | Buy |
42,020
+18,280
| +77% | +$119K | ﹤0.01% | 4847 |
|
|
2023
Q2 | $168K | Buy |
23,740
+12,550
| +112% | +$89.8K | ﹤0.01% | 4911 |
|
|
2023
Q1 | $68K | Sell |
11,190
-12,390
| -53% | -$85.5K | ﹤0.01% | 5450 |
|
|
2022
Q4 | $150K | Buy |
23,580
+18,514
| +365% | +$145K | ﹤0.01% | 5140 |
|
|
2022
Q3 | $48K | Buy |
5,066
+1,787
| +54% | +$20.6K | ﹤0.01% | 5757 |
|
|
2022
Q2 | $36K | Sell |
3,279
-3,175
| -49% | -$41.6K | ﹤0.01% | 5860 |
|
|
2022
Q1 | $107K | Sell |
6,454
-461
| -7% | -$7.13K | ﹤0.01% | 5604 |
|
|
2021
Q4 | $132K | Sell |
6,915
-1,034
| -13% | -$22.8K | ﹤0.01% | 5722 |
|
|
2021
Q3 | $195K | Sell |
7,949
-26,324
| -77% | -$620K | ﹤0.01% | 5202 |
|
|
2021
Q2 | $892K | Buy |
34,273
+31,921
| +1,357% | +$830K | ﹤0.01% | 3758 |
|
|
2021
Q1 | $75K | Sell |
2,352
-3,825
| -62% | -$159K | ﹤0.01% | 5638 |
|
|
2020
Q4 | $286K | Sell |
6,177
-170,790
| -97% | -$6.78M | ﹤0.01% | 4584 |
|
|
2020
Q3 | $5.83M | Buy |
176,967
+21,536
| +14% | +$660K | ﹤0.01% | 1891 |
|
|
2020
Q2 | $4.26M | Buy |
155,431
+48,358
| +45% | +$1.59M | ﹤0.01% | 2054 |
|
|
2020
Q1 | $3.21M | Buy |
107,073
+73,514
| +219% | +$1.95M | ﹤0.01% | 2118 |
|
|
2019
Q4 | $929K | Buy |
33,559
+12,664
| +61% | +$288K | ﹤0.01% | 3501 |
|
|
2019
Q3 | $380K | Buy |
20,895
+19,295
| +1,206% | +$427K | ﹤0.01% | 4021 |
|
|
2019
Q2 | $39K | Sell |
1,600
-500
| -24% | -$7.53K | ﹤0.01% | 5401 |
|
|
2019
Q1 | $20K | Buy |
2,100
+565
| +37% | +$5.49K | ﹤0.01% | 5652 |
|
|
2018
Q4 | $14K | Sell |
1,535
-2,155
| -58% | -$20.8K | ﹤0.01% | 5733 |
|
|
2018
Q3 | $42K | Buy |
3,690
+2,118
| +135% | +$30.1K | ﹤0.01% | 5320 |
|
|
2018
Q2 | $20K | Sell |
1,572
-1,504
| -49% | -$22K | ﹤0.01% | 5529 |
|
|
2018
Q1 | $52K | Buy |
3,076
+2,008
| +188% | +$30.4K | ﹤0.01% | 5037 |
|
|
2017
Q4 | $9K | Sell |
1,068
-5,273
| -83% | -$42.3K | ﹤0.01% | 5900 |
|
|
2017
Q3 | $50K | Buy |
6,341
+5,490
| +645% | +$34.7K | ﹤0.01% | 5413 |
|
|
2017
Q2 | $6K | Sell |
851
-1,977
| -70% | -$12.6K | ﹤0.01% | 5980 |
|
|
2017
Q1 | $21K | Sell |
2,828
-995
| -26% | -$7.29K | ﹤0.01% | 5595 |
|
|
2016
Q4 | $26K | Buy |
3,823
+2,968
| +347% | +$20.4K | ﹤0.01% | 5621 |
|
|
2016
Q3 | $7K | Buy |
855
+100
| +13% | +$846 | ﹤0.01% | 5886 |
|
|
2016
Q2 | $6K | Buy |
755
+200
| +36% | +$1.26K | ﹤0.01% | 5894 |
|
|
2016
Q1 | $3K | Sell |
555
-59
| -10% | -$323 | ﹤0.01% | 6046 |
|
|
2015
Q4 | $5K | Sell |
614
-1,529
| -71% | -$10.6K | ﹤0.01% | 6156 |
|
|
2015
Q3 | $12K | Sell |
2,143
-497
| -19% | -$3.87K | ﹤0.01% | 5805 |
|
|
2015
Q2 | $24K | Buy |
2,640
+2,440
| +1,220% | +$27.2K | ﹤0.01% | 5610 |
|
|
2015
Q1 | $2K | Buy |
+200
| New | +$2.25K | ﹤0.01% | 5905 |
|
Other funds holding IOVA
MFM
VCM
VPM
ICM